<DOC>
	<DOCNO>NCT01125930</DOCNO>
	<brief_summary>Erythematotelangiectatic rosacea type rosacea cause red face often frequent flushing , topical sensitivity prominent blood vessel . We think long term damage skin sun ( photodamage ) may play role cause type rosacea . Tretinoin topical medication know improve photodamage . We want find Atralin ( tretinoin 0.05 % ) Gel use 46 week improve erythematotelangiectatic rosacea ( ETR ) .</brief_summary>
	<brief_title>Atralin Gel Treatment Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>1 . Subjects 18 year age old race . 2 . Clinical diagnosis mild moderate erythematotelangiectatic facial rosacea base physician evaluation . 3 . Willing able understand sign inform consent . 4 . Able complete study comply study procedure . 1 . Severe self report facial sensitivity 2 . History allergy fish 3 . Severe sun sensitivity 4 . Severe erythematotelangiectatic rosacea require systemic treatment 5 . Papulopustular , Ocularonly , Phymatous rosacea , Steroid rosacea , pyoderma faciale 6 . Unwilling undergo facial biopsy 7 . Concomitant use medication report exacerbate rosacea , topical systemic steroid 8 . Use topical rosacea treatment past 2 week . 9 . Use systemic antibiotic past 4 week . 10 . Use systemic retinoids within past 6 month . 11 . Use topical retinoids within past 3 month 12 . Use laser light base rosacea treatment within past 2 month . 13 . Cosmetic procedure ( e.g. , superficial chemical peel , exfoliation microdermabrasion face ) within past two month 14 . Use topical antiaging medication include alpha hydroxy acid , salicylic acid , betahydroxy acid , vitamin A , vitamin E , ascorbic acid 15 . Other dermatologic condition require use interfering topical systemic therapy might interfere study assessment . 16 . Clinically significant abnormal finding condition ( rosacea ) , might , opinion Investigator , interfere study evaluation pose risk subject safety study . 17 . If female , Subjects either nonchild bearing potential ( define postmenopausal absence menstrual bleeding 1 year undergone bilateral tubal ligation , hysterectomy bilateral ovariectomy ) , childbearing potential , Subjects negative urine pregnancy test beginning study , agree practice appropriate birthcontrol prevent pregnancy study . ( The type dose birth control must stable least 2 month prior study entry expect change study ) . 18 . Subjects lactate . 19 . Use investigational therapy within past 4 week . 20 . Known hypersensitivity previous allergic reaction retinoids 21 . Carcinoid , Pheochromocytoma systemic flushing cause</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>rosacea</keyword>
	<keyword>tretinoin</keyword>
	<keyword>atralin</keyword>
</DOC>